1683

US in regulation talks with EU

Equivalence is on agenda for Frankfurt meeting

1662

Japanese insurers and the "Solvency II effect"

Last week Eiopa reported that Japan meets the criteria for equivalence assessment under Solvency II, but with certain caveats. Kunihisa Kawasaki describes the steps Japan has taken to update its risk-based capital insurance framework but says the country can't just "cut and paste" Solvency II.

1643

European Parliament proposes extensive changes to Omnibus II and Solvency II

Proposing a shift in the full implementation date of Solvency II to 2014 was by no means the only significant item in the draft report on Omnibus II from the Committee on Economic and Monetary Affairs, published on 27 July, as William Coatesworth and John McKenzie of Milliman explain.

1630

Bermuda awaits Eiopa's equivalence review

Bermuda's bid for "equivalence" with Europe under Solvency II has generated regulatory moves that are similar to those in the directive. Ahead of the results of Eiopa's assessment of the island's insurance regime, Lorna Davies gauges opinion in Bermuda.

1629

Document: the Committee on Economic and Monetary Affairs' report on Omnibus II

The Committee on Economic and Monetary Affairs of the European Parliament issued its draft report on the proposed Omnibus II on 27 July.

1608

Eiopa consults on Solvency II reporting

Seeks feedback on XBRL taxonomy

1604

BMA to extend use of internal capital models

Small commercial insurers will be allowed them

1588

Should insurers be stressing over Eiopa's capital tests?

Eiopa's insurance stress tests have come under fire, and with Solvency II still in development are they out of date already? Lorna Davies reports.

1583

Solvency II: to delay or not to delay?

A delay to Solvency II appears inevitable, but there are competing views as to how this should be achieved. Michael Faulkner reports on the implications of a postponement.

1582

Eiopa warns of sovereign risk to insurers

But sector can cope with protracted low interest rates, says Eiopa